IMMUNOLOGICAL REACTIVITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I DERIVED PEPTIDE REPRESENTING A CONSENSUS SEQUENCE OF THE GP-120 MAJOR NEUTRALIZING REGION V3

被引:17
作者
WAGNER, R
MODROW, S
BOLTZ, T
FLIESSBACH, H
NIEDRIG, M
VONBRUNN, A
WOLF, H
机构
[1] UNIV REGENSBURG, INST MED MIKROBIOL & HYG, FRANZ JOSEF STR ALLEE 11, W-8400 REGENSBURG, GERMANY
[2] UNIV MUNICH, MAX VON PETTENKOFER INST, W-8000 MUNICH 2, GERMANY
[3] UNIV MUNICH, DEPT BOT, W-8000 MUNICH 2, GERMANY
[4] BEHRINGWERKE AG, W-3550 MARBURG, GERMANY
关键词
D O I
10.1007/BF01309580
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To reduce the opportunities for human immunodeficiency virus type 1 (HIV-1) to evade vaccine induced immunity, the development of subunit vaccines must focus on the characterization of immunogenic epitopes, which are major targets for the immune system. The most dominant site for elicitation of neutralising immune response is located on the external envelope glycoprotein gp 120 within the third variable domain (V3). To overcome virus type specificity of antibodies directed to the V3-domain we designed a 36 amino acids long gp 120/V3-consensus peptide (V3-C36) based on published biological data and sequence comparisons of various HIV-1 virus isolates. This peptide contains a conserved core sequence which is suggested to form a surface-exposed beta-turn. This peptide also includes T-cell epitopes defined in mice and humans, an ADCC-epitope and two highly conserved cysteine residues which were oxidized to form a cystine derivate, thus allowing correct peptide folding. In ELISA-tests, this peptide reacts with at least 90% of randomly selected sera of European and African patients infected with HIV-1 and is recognized by three different HIV-1/V3 "type-specific" antisera (MN, RF, IIIB-strain). Using this peptide as immunogen in rabbits, antisera could be raised with highly cross-reactive and HIV-1/IIIB strain neutralizing properties. Moreover, HTLV/HIV-1/IIIB specific cytotoxic T-lymphocytes (CTLs) of BALB/c mice infected with a gp 120 recombinant vaccinia virus recognized the central 16- and 12-mer peptides of the V3-C36 consensus peptide in cytolytic assays, indicating perfect compatibility of the consensus peptide with the IIIB-primed CTLs. The DNA-sequence encoding the V3-consensus loop region might be an important component in newly designed recombinant subunit vaccines. In addition, due to its broad serological reactivity, the V3-consensus peptide might play an important role in special diagnostic purposes.
引用
收藏
页码:139 / 152
页数:14
相关论文
共 31 条
  • [1] PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160
    BERMAN, PW
    GREGORY, TJ
    RIDDLE, L
    NAKAMURA, GR
    CHAMPE, MA
    PORTER, JP
    WURM, FM
    HERSHBERG, RD
    COBB, EK
    EICHBERG, JW
    [J]. NATURE, 1990, 345 (6276) : 622 - 625
  • [2] BOTTIGER B, 1990, J VIROL, V64, P3492
  • [3] THE V3 LOOPS OF THE HIV-1 AND HIV-2 SURFACE GLYCOPROTEINS CONTAIN PROTEOLYTIC CLEAVAGE SITES - A POSSIBLE FUNCTION IN VIRAL FUSION
    CLEMENTS, GJ
    PRICEJONES, MJ
    STEPHENS, PE
    SUTTON, C
    SCHULZ, TF
    CLAPHAM, PR
    MCKEATING, JA
    MCCLURE, MO
    THOMSON, S
    MARSH, M
    KAY, J
    WEISS, RA
    MOORE, JP
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (01) : 3 - 16
  • [4] INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS
    CLERICI, M
    STOCKS, NI
    ZAJAC, RA
    BOSWELL, RN
    BERNSTEIN, DC
    MANN, DL
    SHEARER, GM
    BERZOFSKY, JA
    [J]. NATURE, 1989, 339 (6223) : 383 - 385
  • [5] CLERICI M, 1991, J IMMUNOL, V146, P2214
  • [6] VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IS CORRELATED WITH THE ABSENCE OF HIGH-AFFINITY AVIDITY MATERNAL ANTIBODIES TO THE GP120 PRINCIPAL NEUTRALIZING DOMAIN
    DEVASH, Y
    CALVELLI, TA
    WOOD, DG
    REAGAN, KJ
    RUBINSTEIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3445 - 3449
  • [7] HIV-1 NEUTRALIZING MONOCLONAL-ANTIBODIES INDUCED BY A SYNTHETIC PEPTIDE
    DURDA, PJ
    BACHELER, L
    CLAPHAM, P
    JENOSKI, AM
    LEECE, B
    MATTHEWS, TJ
    MCKNIGHT, A
    POMERANTZ, R
    RAYNER, M
    WEINHOLD, KJ
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) : 1115 - 1123
  • [8] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES
    GOUDSMIT, J
    DEBOUCK, C
    MELOEN, RH
    SMIT, L
    BAKKER, M
    ASHER, DM
    WOLFF, AV
    GIBBS, CJ
    GAJDUSEK, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) : 4478 - 4482
  • [9] LINEAR VERSUS CONFORMATIONAL VARIATION OF V3 NEUTRALIZATION DOMAINS OF HIV-1 DURING EXPERIMENTAL AND NATURAL INFECTION
    GOUDSMIT, J
    KUIKEN, CL
    NARA, PL
    [J]. AIDS, 1989, 3 : S119 - S123
  • [10] DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS AND OTHER RETROVIRUSES IN CELL-CULTURE SUPERNATANTS BY A REVERSE-TRANSCRIPTASE MICROASSAY
    GREGERSEN, JP
    WEGE, H
    PREISS, L
    JENTSCH, KD
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1988, 19 (02) : 161 - 168